@article{5f0b473224934332b59df707b19259d4,
title = "Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop",
abstract = "Abstract: This brief report collects the program and abstracts of the Society on NeuroImmune Pharmacology (SNIP) COVID-19 Virtual Workshop held on April 9, 2021. The workshop consisted of four symposia: Symposium 1: Molecular approaches to COVID-19 pathogenesis and underlying mechanisms; Symposium 2: Therapeutic and vaccine approaches to COVID-19; Symposium 3: Early Career Investigator talks; and Symposium 4: Diversity and Inclusion SNIP Committee (DISC) program: Well-being and reflections. The workshop also featured four special talks on COVID-19 and funding opportunities from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); COVID-19 and funding opportunities from the National Institute on Drug Abuse (NIDA); opportunities from NIH for early career investigator (ECI) fellows; and neurologic and psychiatric complications of SARS-CoV-2 infection. Presenters included NIH officials, SNIP members, and non-member scientists whose abstracts were submitted and accepted for inclusion in the virtual event hosted by the University of Nebraska Medical Center via Zoom webinar. A special theme issue of SNIP's official journal, the Journal of Neuroimmune Pharmacology (JNIP), will collect select papers from the workshop along with other related manuscripts in a special theme issue titled {"}Neuroimmune Pharmacology of SARS-CoV-2.” Graphical abstract: [Figure not available: see fulltext.]",
keywords = "COVID-19, Diversity and Inclusion, Early career investigators, Neuroimmune pharmacology, SARS-CoV-2, Therapeutics, Vaccines, Well-being",
author = "Santosh Kumar and Gurudutt Pendyala and Yelamanchili, {Sowmya V.} and Pankaj Seth and Sanjay Maggirwar and Bidlack, {Jean M.} and Chang, {Sulie L.}",
note = "Funding Information: This work was supported by the University of Miami COVID-19 Rapid Response Grant, award number UM 2020-2224 and by the National Institutes of Health (NIH), grants MH098891, MH072567, HL126559, DA039576, DA040537, and DA044579. Dr. S. Torices was supported by an AHA postdoctoral fellowship (20POST35211181). Dr. Adesse was supported by Funda{\c c}{\~a}o Oswaldo Cruz (INOVA Fiocruz, grant number 48401984391807) and Funda{\c c}{\~a}o de Amparo {\`a} Pesquisa do Estado do Rio de Janeiro (FAPERJ, SEI-260003/002704/2020). Funding Information: We thank the National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism, and National Institute of Mental Health for their significant contribution to this virtual workshop. We also thank the Journal of Neuroimmune Pharmacology for publishing this brief report on our workshop. Furthermore, the authors thank Mr. Doug Meigs and Mr. Bryan Knoelk from the University of Nebraska Medical Center in hosting the workshop?s Zoom webinar. Funding Information: The meeting, in part, was supported by the National Institute on Drug Abuse (DA047178 to S Kumar and DA046258 to SL Chang). Funding Information: Supported by the National Institutes of Health (NIH), grants DA044579, DA039576, DA040537, DA050528, DA047157, MH122235, MH072567, and HL126559. Dr. Adesse was supported by Funda{\c c}{\~a}o Oswaldo Cruz (INOVA Fiocruz, grant number 48401984391807) and Funda{\c c}{\~a}o de Amparo {\`a} Pesquisa do Estado do Rio de Janeiro (FAPERJ, SEI-260003/002704/2020). Publisher Copyright: {\textcopyright} 2021, Springer Science+Business Media, LLC, part of Springer Nature.",
year = "2021",
month = sep,
doi = "10.1007/s11481-021-10001-y",
language = "English (US)",
volume = "16",
pages = "519--530",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "3",
}